The Global Flow Cytometry Market is expected to grow at a CAGR of 8.2% from 2019 to 2027 to reach at $6.36 billion by 2027. Flow cytometry is a widely used method for analyzing cell size & volume, assessing the purity of isolated subpopulations, characterizing & defining different cell types in a heterogeneous cell population, […]Read More..
The unique ability to specifically bind to the nucleic acid sequence makes oligonucleotide (ON) a promising agent in the medical field. Moreover, the capability of ONs to exert the aforementioned biological mechanisms via sequence-specific molecular recognition makes them highly attractive candidates for drug development. Here are Top 10 companies in oligonucleotide – Danaher Corporation Founded […]Read More..
Global Downstream Bio-Processing Controllers Market will grow at a CAGR of 17.3% during the forecast period to reach $1,92 billion by 2025 from $0.74 billion in 2019, Says “Meticulous Research®”. Downstream bio-processing is a process in biopharmaceutical manufacturing to recover the pure protein from contaminant proteins. The growth in this market is majorly driven by […]Read More..
Laboratory informatics solutions help to reduce manual efforts, labor cost, cost of error, and throughput time; offer paperless information management and effective data analytics; improve data traceability, accessibility, security and sharing; streamline processes; enhance quality management; abide by the regulatory requirements; and provide better control of all business processes and decision support. Thus, automation of […]Read More..
Growth of global IVD market is driven by rising geriatric population and subsequent growth in the prevalence of chronic and infectious diseases, increasing adoption of fully automated instruments and automation in laboratories, and growing adoption of personalized medicine and point-of-care testing. Development of condition-specific markers and tests and growing demand for IVD products in emerging […]Read More..
With the growing need to achieve better value for healthcare, the importance of real-world evidence (RWE) as a decision-making tool and an important part of drug development and commercialization has also raised. Pharma and biopharma companies now recognize the need to get a better understanding and stronger evidence of product performance, clinical value and cost […]Read More..
The clinical trial materials and supplies market is expected to grow at a CAGR of 6% from 2019 to reach $25.9 billion by 2025. Clinical trials have a vigorous supply chain management of the drugs considering the stringency of the regulations and the availability of the infrastructure for the efficient execution. The drug manufacturers and […]Read More..
The Global Patient Registry Software Market is expected to grow at a CAGR of 11.0% from 2018 to 2023 to reach USD 1.49 billion by 2023. With growing efforts for the adoption of electronic health records (EHRs) across the globe, and rising importance of evidence-based data from registries for effectiveness, safety and quality, the market […]Read More..
The global antimicrobial susceptibility testing market is expected to grow at a CAGR of around 6.1% from 2019 to 2027 to reach at $5.09 billion by 2027. Susceptibility testing is used in the determination of the antimicrobials inhibiting the growth of the bacteria or fungi causing a specific infection. The aim of antimicrobial susceptibility testing […]Read More..
An immunoassay is a chemical test used to detect or quantify a specific substance using an immunological reaction. Immunoassays are utilized in healthcare industry in diagnostics applications, such as infectious diseases, endocrinology, oncology, bone & mineral disorders, cardiology, hematology & blood screening, autoimmune disorders, neonatal screening, and in toxicology testing. The immunoassay market is expected […]Read More..